In this context, a recent study on the B16 murine model demonstrated that ADAR1 suppression in cancer cells had a profound impact on TME and enhanced antitumor immunity, as it caused a global reshaping of tumor-infiltrating lymphocytes and sensitized tumors to immunotherapy and to IFNs (19). The gene discussed is ADAR; the disease is cancer.